AEHR TEST SYSTEMS
At today's price, AEHR TEST SYSTEMS (AEHR) is priced for today's economics sustained for ~40.0 years+. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
Aehr Test Systems is a small semiconductor test and burn-in maker priced as a growth story, not as the business its current financials describe. At $115.51 the price reads against sales at roughly 73x revenue, the most demanding end of the scale, because the company is loss-making and burning cash on a trailing basis. The story is the pivot away from silicon-carbide EV concentration toward AI processors, data-center burn-in, gallium nitride, and silicon photonics. Q3 fiscal 2026 bookings jumped
Is AEHR overvalued? See what's priced in →
180 institutional managers reported holding AEHR in 13F filings for the quarter ended 2026-03-31. Together they hold about 73% of the company; the top 10 hold 46%. 54 opened new positions that quarter. Held by Vanguard Group, BlackRock, FMR (Fidelity), among others. On the short side, 4.0M shares were sold short as of the 2026-06-15 count, about 13% of shares outstanding (2 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
AEHR's share count grew 17.5% over the past five years. It pays no dividend.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at AEHR over the trailing three years: 2023: 1 buy totaling $28k; 2024: 4 buys totaling $461k. 14 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
AEHR's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-29 | +3.3% | -51.1% |
| 2023-10-13 | -14.4% | -28.6% |
| 2024-01-13 | -18.4% | -18.6% |
| 2024-04-11 | -0.9% | +15.7% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
AEHR's latest 8-K filings: 2026-07-14 (items 2.02, 9.01); 2026-04-20 (items 8.01, 9.01); 2026-04-08 (items 1.01, 9.01); 2026-04-07 (items 2.02, 5.03, 9.01); 2026-01-08 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.